FDA 483 - Jacob W. Zeiders III, M.D.

An FDA inspection of Jacob W. Zeiders, III, MD, a clinical investigator in North Lauderdale, FL, revealed significant deficiencies in the conduct of a clinical study. Observations included a lack of proper supervision by the clinical investigator, issues with source data attribution and contemporaneity, and subjects failing to adhere to protocol-specified visit timeframes. Additionally, subject case histories were found to be inaccurate.